Ixico Plc (IXI) New Ord GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Ixico awarded ?3.4m contract by existing client
24 December 2020 12:20
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been awarded a £3.4m contract to run over 4.5 years by an existing client, it announced on Thursday, for a spinocerebellar...
-
Ixico to provide neuroimaging solutions to unnamed global pharmaceutical group
8 December 2020 09:26
(Sharecast News) - Data analytics firm Ixico has secured a contract for neuroimaging solutions with a "large global pharmaceutical company".
-
Ixico executes contract for Huntington's disease clinical trial
27 November 2020 12:09
(Sharecast News) - Neuroscience data analytics company Ixico has executed a contract to provide neuroimaging services that would support a phase 1b and 2 clinical trial for Huntington's disease, it...
-
Ixico wins new contracts in Alzheimer's clinical trials
3 November 2020 10:43
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Alzheimer's disease (AD) clinical trials, it announced on Tuesday.
-
Ixico secures two Huntington's disease clinical trial contracts
22 October 2020 15:00
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Huntington's disease clinical trials.
-
Ixico FY revenues grow by more than a quarter
19 October 2020 09:38
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.
-
Ixico enters deal with NUY Langone Health for drug trial
16 October 2020 16:23
(Sharecast News) - Data analytics company Ixico has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus, approved by the FDA to prevent...
-
Ixico joins Friedreich's Ataxia research consortium
24 September 2020 16:30
(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a...
-
Ixico joins Friedreich's Ataxia research consortium
24 September 2020 16:30
(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a...
-
Ixico selected to support Alzheimer's trial
21 September 2020 13:35
(Sharecast News) - Data analytics company Ixico has been selected by the Global Alzheimer's Platform Foundation (GAP) to support its planned 'Bio-Hermes' trial.
-
Ixico FY revenues, underlying earnings ahead of forecasts
24 August 2020 09:18
(Sharecast News) - Data analytics company Ixico said on Monday that it had recorded "stronger-than-anticipated" second-half revenues and underlying earnings despite Covid-19.
-
Ixico sees only 'modest' impact on trading from Covid-19
24 June 2020 09:41
(Sharecast News) - Data analytics company Ixico said on Wednesday that Covid-19 had only had a "modest" impact on trading and stated it expects to maintain double-digit revenue growth in 2021.
Company announcements Announcements
-
IXICO selected by Cyclerion for a new AD study
2 March 2021 07:00
Ixico
-
Exercise of Options; PDMR Dealing
1 March 2021 17:25
Ixico
-
Conference attendance and presentations
1 March 2021 07:00
Ixico
-
PDMR Dealing
29 January 2021 10:19
Ixico
-
Result of AGM
21 January 2021 11:05
Ixico
-
Issue of Equity
7 January 2021 07:00
Ixico
-
IXICO secures new contract for £3.4 million
24 December 2020 07:00
Ixico
-
Holding(s) in Company
14 December 2020 11:54
Ixico
-
IXICO contract with new large global pharma
8 December 2020 07:00
Ixico
-
Second Price Monitoring Extn
3 December 2020 14:06
Ixico
-
Price Monitoring Extension
3 December 2020 14:01
Ixico
-
Financial Results for the year ended 30 Sept 2020
2 December 2020 07:00
Ixico
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.